scholarly journals Cardiopulmonary exercise testing in clinical practice

2021 ◽  
Vol 3 (2) ◽  
pp. 58-70
Author(s):  
Oleg B. Kerbikov ◽  
Alexander V. Averyanov ◽  
Ekaterina N. Borskaya ◽  
Tamara V. Krutova

The review is dedicated to the use of the cardiopulmonary exercise testing (CPET) in clinical practice. Main modes of CPET, most popular protocols and testing methods are discussed in details. Ample space is dedicated to main parameters measuring during CPET, their physiological values and changes in different pathological states. Main indications for CPET are presented and special attention is given to the use of CPET in chronic heart failure, apnea, lung diseases, skeletal muscle fiber and mitochondrial myopathy, rehabilitation. Emerging applications of CPET like congenital heart disease, pulmonary resection and several other are also discussed.

2019 ◽  
Vol 54 (6) ◽  
pp. 1901441 ◽  
Author(s):  
Thomas Radtke ◽  
Ioannis Vogiatzis ◽  
Don S. Urquhart ◽  
Pierantonio Laveneziana ◽  
Richard Casaburi ◽  
...  

Cardiology ◽  
1987 ◽  
Vol 74 (1) ◽  
pp. 62-70 ◽  
Author(s):  
Karl T. Weber ◽  
Joseph S. Janicki ◽  
Patricia A. McElroy ◽  
Carol S. Maskin

Author(s):  
Gonçalo António Cintrão Samouco ◽  
Rebeca Natal ◽  
João Costa ◽  
Andreia Filipa Carriço ◽  
Ana Filipa Fernandes ◽  
...  

Author(s):  
Carolina España Dominguez ◽  
María Morales González ◽  
Alfonso Marín Andreu ◽  
Aurelio Arnedillo Muñoz ◽  
Isabel Muñoz Ramírez

2019 ◽  
Vol 28 (154) ◽  
pp. 180101 ◽  
Author(s):  
Thomas Radtke ◽  
Sarah Crook ◽  
Georgios Kaltsakas ◽  
Zafeiris Louvaris ◽  
Danilo Berton ◽  
...  

The objective of this document was to standardise published cardiopulmonary exercise testing (CPET) protocols for improved interpretation in clinical settings and multicentre research projects. This document: 1) summarises the protocols and procedures used in published studies focusing on incremental CPET in chronic lung conditions; 2) presents standard incremental protocols for CPET on a stationary cycle ergometer and a treadmill; and 3) provides patients' perspectives on CPET obtained through an online survey supported by the European Lung Foundation. We systematically reviewed published studies obtained from EMBASE, Medline, Scopus, Web of Science and the Cochrane Library from inception to January 2017. Of 7914 identified studies, 595 studies with 26 523 subjects were included. The literature supports a test protocol with a resting phase lasting at least 3 min, a 3-min unloaded phase, and an 8- to 12-min incremental phase with work rate increased linearly at least every minute, followed by a recovery phase of at least 2–3 min. Patients responding to the survey (n=295) perceived CPET as highly beneficial for their diagnostic assessment and informed the Task Force consensus. Future research should focus on the individualised estimation of optimal work rate increments across different lung diseases, and the collection of robust normative data.


2020 ◽  
Vol 2 (3) ◽  
pp. 327-331
Author(s):  
Owen William Tomlinson ◽  
Jayne Trott ◽  
Craig Anthony Williams ◽  
Nicholas John Withers ◽  
Patrick John Oades

2021 ◽  
Vol 30 (162) ◽  
pp. 200355
Author(s):  
Thomas Gille ◽  
Pierantonio Laveneziana

Interstitial lung diseases (ILDs) are diverse parenchymal pulmonary disorders, primarily characterised by alveolar and interstitial inflammation and/or fibrosis, and sharing pathophysiological similarities. Thus, patients generally harbour common respiratory symptoms, lung function abnormalities and modified exercise adaptation. The most usual and disabling complaint is exertional dyspnoea, frequently responsible for premature exercise interruption. Cardiopulmonary exercise testing (CPET) is increasingly used for the clinical assessment of patients with ILD. This is because exercise performance or dyspnoea on exertion cannot reliably be predicted by resting pulmonary function tests. CPET, therefore, provides an accurate evaluation of functional capacity on an individual basis. CPET can unmask anomalies in the integrated functions of the respiratory, cardiovascular, metabolic, peripheral muscle and neurosensory systems in ILDs. CPET uniquely provides an evaluation of all above aspects and can help clinicians shape ILD patient management. Preliminary evidence suggests that CPET may also generate valuable prognostic information in ILDs and can be used to shed light on the presence of associated pulmonary hypertension. This review aims to provide comprehensive and updated evidence concerning the clinical utility of CPET in ILD patients, with particular focus on the physiological and clinical value of ventilatory efficiency (V˙E/V˙CO2).


Sign in / Sign up

Export Citation Format

Share Document